Fitting selected WB targets into the broader network of neurodegenerative protein interactions. by Diego Iacono (10785756)

The effect of caspase-1 inhibitor on HIV-induced changes in IL-18 and IL-18BP in IEC. by Ossama Allam (5043434)

Synergistic Voltaglue Adhesive Mechanisms with Alternating Electric Fields by Manisha Singh (12171)

“…Numerous improvements in electrocuring are observed with AC stimulation vs direct current, including a 35% decrease in maximum voltage, 180% improvement in kinetic rates, and 100% increase in lap-shear adhesion at 2 mA. …”

Synergistic Voltaglue Adhesive Mechanisms with Alternating Electric Fields by Manisha Singh (12171)

“…Numerous improvements in electrocuring are observed with AC stimulation vs direct current, including a 35% decrease in maximum voltage, 180% improvement in kinetic rates, and 100% increase in lap-shear adhesion at 2 mA. …”

<i>Gpdh1; Ldh</i> double mutants display elevated JNK activation in the larval muscles. by Madhulika Rai (4352803)

Effects of compound 2 on histopathology of liver fibrosis. by Kun-Lin Yang (1390828)

HTRF for high-throughput screening of HCMV NEC inhibitors. by Han Chen (228557)

“…The HTRF ratio for the NEC (signal, S) was ~3-fold higher than the background (B) HTRF ratios for His-UL50 or Myc-UL53 alone (S/B ~3). Untagged UL50 decreased S/B to near background levels, serving as a positive control, while UL50_E56A, which is highly defective for UL53 binding [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011781#ppat.1011781.ref012" target="_blank">12</a>] did not decrease S/B, serving as a negative control. …”

TPM1, TPM4, PCP4 and NPY are identified as having significantly increased abundance in the hippocampus after LDR exposure. by Diego Iacono (10785756)

Pharmacological α7 nAChR activation mediates spectrin breakdown. by Justin R. King (793933)

Evaluation of PIT effects in a disseminated peritoneal model. by Kazuhide Sato (662171)

“…<p>(A) PIT regimen. Real-time GFP fluorescence imaging was obtained at each time point indicated. …”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Calcium levels in PC12 cells exposed to SMF, the A_2AR agonist CGS21680 or antagonist ZM241385. by Zhiyun Wang (360002)

“…<p>(<b>A</b>) Extracellular Ca²⁺ was measured for cells maintained in calcium-free medium increased for time points up to 3.0 h in response to SMF exposure; <i>p</i><0.05 for n = 3 independent experiments. …”

Formation and removal of disc. by William Ebo Annan (18784259)

RNA expression of <i>KRT6, KRT10, S100A8, S100A9, p21, and HMOX-1</i>. by Emiliano Fratini (223406)

“…<i>KRT10</i> showed a tendency to decrease (statistically not significant) in all treated samples. …”

Gonadal development and sex ratios as a function of TL. by Frederic H. Martini (481487)

“…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”

Closed loop stimulation (CLS) simulation results. by Muhammad Mushtaq (788834)

“…<p><b><i>A</i></b>, Power spectral density (PSD) of the cortical LFP across a 300 s time period with “Point 1” (green), “Point 4” stimulation (red), and Control (black) simulation. …”